Tag: FDA
EMA recommends approving GSK’s oral therapy for rare blood cancer
A decision on EU marketing authorisation for oral therapy is expected by early 2024.
The Committee for Medicinal Products for Human Use (CHMP) of...
MHRA gives nod for a new therapy to treat lung cancer
The new therapy is said to 'slow down' or 'stop the growth' of the cancer
The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved...
Elsevier unveiled PharmaPendium: a drug development decision-making platform
The new drug research initiative provides preclinical and clinical data that enable researchers to make informed decisions regarding drug enhancement
The global company in information...
CVS Health halts sale of phenylephrine cold and cough products
The panel of advisors pulled the OTC medicine from the shelves due to its ineffectiveness in unblocking stuffy nose
The American healthcare company, CVS Health,...
Eisai files for approval of Alzheimer’s drug in Europe
Japanese drugmaker Eisai said on Tuesday (January 10) it had submitted a marketing application to the European health regulator for review of its Alzheimer's...